Cargando…
Management of hypertension in COVID-19
The ACE2 receptor plays a central role in severe acute respiratory syndrome coronavirus 2 host cell entry and propagation. It has therefore been postulated that angiotensin converting enzyme inhibitors and angiotensin receptor blockers may upregulate ACE2 expression and thus increase susceptibility...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283999/ https://www.ncbi.nlm.nih.gov/pubmed/32547717 http://dx.doi.org/10.4330/wjc.v12.i5.228 |
_version_ | 1783544376417320960 |
---|---|
author | Antwi-Amoabeng, Daniel Beutler, Bryce D Moody, Alastair E Kanji, Zahara Gullapalli, Nageshwara Rowan, Christopher J |
author_facet | Antwi-Amoabeng, Daniel Beutler, Bryce D Moody, Alastair E Kanji, Zahara Gullapalli, Nageshwara Rowan, Christopher J |
author_sort | Antwi-Amoabeng, Daniel |
collection | PubMed |
description | The ACE2 receptor plays a central role in severe acute respiratory syndrome coronavirus 2 host cell entry and propagation. It has therefore been postulated that angiotensin converting enzyme inhibitors and angiotensin receptor blockers may upregulate ACE2 expression and thus increase susceptibility to infection. We suggest that alternative anti-hypertensive agents should be preferred among individuals who may be exposed to this increasingly common and potentially lethal virus. |
format | Online Article Text |
id | pubmed-7283999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-72839992020-06-15 Management of hypertension in COVID-19 Antwi-Amoabeng, Daniel Beutler, Bryce D Moody, Alastair E Kanji, Zahara Gullapalli, Nageshwara Rowan, Christopher J World J Cardiol Letter To The Editor The ACE2 receptor plays a central role in severe acute respiratory syndrome coronavirus 2 host cell entry and propagation. It has therefore been postulated that angiotensin converting enzyme inhibitors and angiotensin receptor blockers may upregulate ACE2 expression and thus increase susceptibility to infection. We suggest that alternative anti-hypertensive agents should be preferred among individuals who may be exposed to this increasingly common and potentially lethal virus. Baishideng Publishing Group Inc 2020-05-26 2020-05-26 /pmc/articles/PMC7283999/ /pubmed/32547717 http://dx.doi.org/10.4330/wjc.v12.i5.228 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Letter To The Editor Antwi-Amoabeng, Daniel Beutler, Bryce D Moody, Alastair E Kanji, Zahara Gullapalli, Nageshwara Rowan, Christopher J Management of hypertension in COVID-19 |
title | Management of hypertension in COVID-19 |
title_full | Management of hypertension in COVID-19 |
title_fullStr | Management of hypertension in COVID-19 |
title_full_unstemmed | Management of hypertension in COVID-19 |
title_short | Management of hypertension in COVID-19 |
title_sort | management of hypertension in covid-19 |
topic | Letter To The Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283999/ https://www.ncbi.nlm.nih.gov/pubmed/32547717 http://dx.doi.org/10.4330/wjc.v12.i5.228 |
work_keys_str_mv | AT antwiamoabengdaniel managementofhypertensionincovid19 AT beutlerbryced managementofhypertensionincovid19 AT moodyalastaire managementofhypertensionincovid19 AT kanjizahara managementofhypertensionincovid19 AT gullapallinageshwara managementofhypertensionincovid19 AT rowanchristopherj managementofhypertensionincovid19 |